IJNP goes fully electronic: new online manuscript submission and review system implemented.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 379, doi. 10.1017/s1461145704004833
- By:
- Publication type:
- Article
Works matching IS 14611457 AND DT 2004 AND VI 7 AND IP 4
Results: 21
1
2
Association of the C(1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 501, doi. 10.1017/s1461145704004699
- By:
- Publication type:
- Article
3
Erratum.
- Published in:
- 2004
- Publication type:
- Erratum
4
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 387, doi. 10.1017/s1461145704004535
- By:
- Publication type:
- Article
5
Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 481, doi. 10.1017/s1461145704004626
- By:
- Publication type:
- Article
6
Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics See Huang et al. (this issue). Human 5-HT1A receptor C(1019)G polymorphism and psychopathology; Lemonde et al. (this issue). Association of the C(1019)G 5-HT1A functional promoter polymorphism with antidepressant response; Serretti et al. (this issue). The C(1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 381, doi. 10.1017/s1461145704004845
- By:
- Publication type:
- Article
7
Human 5-HT1A receptor C(−1019)G polymorphism and psychopathology.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 441, doi. 10.1017/s1461145704004663
- By:
- Publication type:
- Article
8
The C(1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 453, doi. 10.1017/s1461145704004687
- By:
- Publication type:
- Article
9
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 507, doi. 10.1017/s1461145704004651
- By:
- Publication type:
- Article
10
Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 489, doi. 10.1017/s1461145704004614
- By:
- Publication type:
- Article
11
Sildenafil-induced relapse in bipolar disorder: is nitric oxide the mechanism?
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 525, doi. 10.1017/s146114570400464x
- By:
- Publication type:
- Article
12
Buspirone to improve compliance in venlafaxine-induced movement disorder.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 523, doi. 10.1017/s1461145704004638
- By:
- Publication type:
- Article
13
Repetitive transcranial magnetic stimulation as an antidepressant monotherapy in a patient with major depression, leucocytopenia and rhabdomyolysis.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 527, doi. 10.1017/s1461145704004523
- By:
- Publication type:
- Article
14
Effects of fluoxetine on dopamine D<sub>2</sub> receptors in the human brain: a positron emission tomography study with [<sup>11</sup>C]raclopride.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 431, doi. 10.1017/s146114570400450x
- By:
- Publication type:
- Article
15
Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 401, doi. 10.1017/s1461145704004493
- By:
- Publication type:
- Article
16
Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 495, doi. 10.1017/s1461145704004419
- By:
- Publication type:
- Article
17
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 471, doi. 10.1017/s1461145704004407
- By:
- Publication type:
- Article
18
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 415, doi. 10.1017/s1461145704004390
- By:
- Publication type:
- Article
19
Effects of dopamine D<sub>2</sub> receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 461, doi. 10.1017/s1461145704004389
- By:
- Publication type:
- Article
20
In-vivo modulation of central 5-hydroxytryptamine (5-HT<sub>1A</sub>) receptor-mediated responses by the cholinergic system.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 391, doi. 10.1017/s1461145704004377
- By:
- Publication type:
- Article
21
High striatal occupancy of D<sub>2</sub>-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 421, doi. 10.1017/s1461145704004353
- By:
- Publication type:
- Article